Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Pediatric melanoma in melanoma-prone families.

Goldstein AM, Stidd KC, Yang XR, Fraser MC, Tucker MA.

Cancer. 2018 Sep 15;124(18):3715-3723. doi: 10.1002/cncr.31641. Epub 2018 Sep 12.

2.

Risks of Melanoma and Other Cancers in Melanoma-Prone Families over 4 Decades.

Tucker MA, Elder DE, Curry M, Fraser MC, Pichler V, Zametkin D, Yang XR, Goldstein AM.

J Invest Dermatol. 2018 Jul;138(7):1620-1626. doi: 10.1016/j.jid.2018.01.021. Epub 2018 Feb 8.

3.

dna and DNA: linked for life.

Fraser MC.

Dermatol Nurs. 2008 Apr;20(2):102. No abstract available.

PMID:
18549124
4.

Genetic testing for melanoma predisposition: current challenges.

Gerstenblith MR, Goldstein AM, Tucker MA, Fraser MC.

Cancer Nurs. 2007 Nov-Dec;30(6):452-9; quiz 462-3. Review.

PMID:
18025917
5.

Recent tanning bed use: a risk factor for melanoma.

Buckel TB, Goldstein AM, Fraser MC, Rogers B, Tucker MA.

Arch Dermatol. 2006 Apr;142(4):485-8.

PMID:
16618869
6.

Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.

Goldstein AM, Landi MT, Tsang S, Fraser MC, Munroe DJ, Tucker MA.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2208-12.

7.

Prospective risk of cancer in CDKN2A germline mutation carriers.

Goldstein AM, Struewing JP, Fraser MC, Smith MW, Tucker MA.

J Med Genet. 2004 Jun;41(6):421-4.

8.

Genetic testing for inherited predisposition to melanoma: has the time come?

Fraser MC, Goldstein AM, Tucker MA; Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland, USA.

J Drugs Dermatol. 2004 Jan-Feb;3(1):93-5. No abstract available.

PMID:
14964756
9.

A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.

Tucker MA, Fraser MC, Goldstein AM, Struewing JP, King MA, Crawford JT, Chiazze EA, Zametkin DP, Fontaine LS, Clark WH Jr.

Cancer. 2002 Jun 15;94(12):3192-209.

10.

Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.

Goldstein AM, Struewing JP, Chidambaram A, Fraser MC, Tucker MA.

J Natl Cancer Inst. 2000 Jun 21;92(12):1006-10.

PMID:
10861313
11.

The National Cancer Program.

Wujcik D, Fraser MC.

Semin Oncol Nurs. 2000 Feb;16(1):65-75. Review.

PMID:
10701242
12.

High prevalence of antibodies against HERV-K10 in patients with testicular cancer but not with AIDS.

Goedert JJ, Sauter ME, Jacobson LP, Vessella RL, Hilgartner MW, Leitman SF, Fraser MC, Mueller-Lantzsch NG.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 1):293-6.

13.

Sun-related risk factors in melanoma-prone families with CDKN2A mutations.

Goldstein AM, Falk RT, Fraser MC, Dracopoli NC, Sikorski RS, Clark WH Jr, Tucker MA.

J Natl Cancer Inst. 1998 May 6;90(9):709-11. No abstract available.

PMID:
9586669
14.

The genetics of melanoma.

Fraser MC, Goldstein AM, Tucker MA.

Semin Oncol Nurs. 1997 May;13(2):108-14. Review.

PMID:
9114478
15.

Apparent anticipation in familial melanoma.

Goldstein AM, Clark WH Jr, Fraser MC, Tucker MA.

Melanoma Res. 1996 Dec;6(6):441-6.

PMID:
9013482
16.

Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.

Goldstein AM, Fraser MC, Struewing JP, Hussussian CJ, Ranade K, Zametkin DP, Fontaine LS, Organic SM, Dracopoli NC, Clark WH Jr, et al.

N Engl J Med. 1995 Oct 12;333(15):970-4.

17.

Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families.

Novakovic B, Clark WH Jr, Fears TR, Fraser MC, Tucker MA.

J Am Acad Dermatol. 1995 Oct;33(4):631-6.

PMID:
7673498
18.

Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.

Goldstein AM, Fraser MC, Clark WH Jr, Tucker MA.

J Natl Cancer Inst. 1994 Sep 21;86(18):1385-90.

PMID:
8072031
19.

Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.

Goldstein AM, Dracopoli NC, Engelstein M, Fraser MC, Clark WH Jr, Tucker MA.

Am J Hum Genet. 1994 Mar;54(3):489-96.

20.

Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity.

Goldstein AM, Dracopoli NC, Ho EC, Fraser MC, Kearns KS, Bale SJ, McBride OW, Clark WH Jr, Tucker MA.

Am J Hum Genet. 1993 Mar;52(3):537-50.

21.

Risk of melanoma and other cancers in melanoma-prone families.

Tucker MA, Fraser MC, Goldstein AM, Elder DE, Guerry D 4th, Organic SM.

J Invest Dermatol. 1993 Mar;100(3):350S-355S.

PMID:
8440923
22.

Genodermatoses with profound malignant potential.

Tokar IP, Fraser MC, Bale SJ.

Semin Oncol Nurs. 1992 Nov;8(4):272-80. Review.

PMID:
1480858
23.

Melanoma and nonmelanoma skin cancer: epidemiology and risk factors.

Fraser MC, Hartge P, Tucker MA.

Semin Oncol Nurs. 1991 Feb;7(1):2-12. Review. No abstract available.

PMID:
2011655
24.

Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p.

Bale SJ, Dracopoli NC, Tucker MA, Clark WH Jr, Fraser MC, Stanger BZ, Green P, Donis-Keller H, Housman DE, Greene MH.

N Engl J Med. 1989 May 25;320(21):1367-72. Erratum in: N Engl J Med 1991 Mar 28;324(13):925.

PMID:
2716782
25.

Second malignancies following cancer therapy.

Fraser MC, Tucker MA.

Semin Oncol Nurs. 1989 Feb;5(1):43-55. Review.

PMID:
2646668
26.

Late effects of cancer therapy: chemotherapy-related malignancies.

Fraser MC, Tucker MA.

Oncol Nurs Forum. 1988 Jan-Feb;15(1):67-77. Review. No abstract available.

PMID:
3278303
27.

Hereditary melanoma and the dysplastic nevus syndrome: the risk of cancers other than melanoma.

Greene MH, Tucker MA, Clark WH Jr, Kraemer KH, Elder DE, Fraser MC.

J Am Acad Dermatol. 1987 Apr;16(4):792-7.

PMID:
3571543
28.

Host-susceptibility factors in cancer etiology.

Fraser MC, Tucker MA.

Semin Oncol Nurs. 1986 Aug;2(3):170-5. No abstract available.

PMID:
3638753
29.

Familial testicular cancer and urogenital developmental anomalies.

Tollerud DJ, Blattner WA, Fraser MC, Brown LM, Pottern L, Shapiro E, Kirkemo A, Shawker TH, Javadpour N, O'Connell K, et al.

Cancer. 1985 Apr 15;55(8):1849-54.

PMID:
2858262
30.

High risk of malignant melanoma in melanoma-prone families with dysplastic nevi.

Greene MH, Clark WH Jr, Tucker MA, Kraemer KH, Elder DE, Fraser MC.

Ann Intern Med. 1985 Apr;102(4):458-65.

PMID:
3977193
31.

Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome.

Greene MH, Clark WH Jr, Tucker MA, Elder DE, Kraemer KH, Guerry D 4th, Witmer WK, Thompson J, Matozzo I, Fraser MC.

N Engl J Med. 1985 Jan 10;312(2):91-7. No abstract available.

PMID:
3964923
32.

Skin cancer's early warning system.

Fraser MC, McGuire DB.

Am J Nurs. 1984 Oct;84(10):1232-6. No abstract available.

PMID:
6567449
33.

Managing the dysplastic naevus syndrome.

Greene MH, Clark WH Jr, Tucker MA, Elder DE, Kraemer KH, Guerry D 4th, Fraser MC.

Lancet. 1984 Jan 21;1(8369):166-7. No abstract available.

PMID:
6140476
34.

For the record: the history of precursors to malignant melanoma.

Greene MH, Fraser MC, Clark WH Jr, Elder DE, Guerry D 4th, Kraemer KH.

Arch Dermatol. 1984 Jan;120(1):18-21. No abstract available.

PMID:
6691712
35.

Familial chronic lymphocytic leukemia.

Neuland CY, Blattner WA, Mann DL, Fraser MC, Tsai S, Strong DM.

J Natl Cancer Inst. 1983 Dec;71(6):1143-50.

PMID:
6418939
36.

Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus.

Greene MH, Goldin LR, Clark WH Jr, Lovrien E, Kraemer KH, Tucker MA, Elder DE, Fraser MC, Rowe S.

Proc Natl Acad Sci U S A. 1983 Oct;80(19):6071-5.

37.

Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families.

Tucker MA, Greene MH, Clark WH Jr, Kraemer KH, Fraser MC, Elder DE.

J Pediatr. 1983 Jul;103(1):65-9.

PMID:
6864397
38.

The role of the nurse in the prevention and early detection of malignant melanoma.

Fraser MC.

Cancer Nurs. 1982 Oct;5(5):351-60. No abstract available.

PMID:
6923770
39.

Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature.

Greene MH, Clark WH Jr, Tucker MA, Elder DE, Kraemer KH, Fraser MC, Bondi EE, Guerry D, Tuthill R, Hamilton R, LaRossa D.

Lancet. 1980 Nov 8;2(8202):1024. No abstract available.

PMID:
6107646

Supplemental Content

Loading ...
Support Center